王永炫, 李梅, 章振林, 夏维波. 《原发性骨质疏松症诊疗指南(2022)》要点解读[J]. 协和医学杂志, 2023, 14(6): 1203-1207. DOI: 10.12290/xhyxzz.2023-0364
引用本文: 王永炫, 李梅, 章振林, 夏维波. 《原发性骨质疏松症诊疗指南(2022)》要点解读[J]. 协和医学杂志, 2023, 14(6): 1203-1207. DOI: 10.12290/xhyxzz.2023-0364
WANG Yongxuan, LI Mei, ZHANG Zhenlin, XIA Weibo. Interpretation on the Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2022)[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(6): 1203-1207. DOI: 10.12290/xhyxzz.2023-0364
Citation: WANG Yongxuan, LI Mei, ZHANG Zhenlin, XIA Weibo. Interpretation on the Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2022)[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(6): 1203-1207. DOI: 10.12290/xhyxzz.2023-0364

《原发性骨质疏松症诊疗指南(2022)》要点解读

Interpretation on the Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2022)

  • 摘要: 2022年12月,《原发性骨质疏松症诊疗指南(2022)》发布,指南更新了我国骨质疏松症的最新流行病学数据,结合该领域内的循证医学证据及临床实践经验,对骨质疏松症的诊疗作出了最新推荐。本文对该指南的要点进行解读,以期为医务工作者更好地理解和遵循指南提供帮助。

     

    Abstract: In December 2022, the Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2022) were released. The guidelines have updated the latest epidemiological data of osteoporosis in China and given recommendations for the diagnosis and treatment of osteoporosis by combining evidence-based medical testimony and clinical practice in this field. This article interprets the key points of the guidelines to help healthcare workers better understand and follow the guidelines.

     

/

返回文章
返回